Mydecine Innovations Group Inc.
MYCOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | – | – | – | – |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.043 | -0 | -0.005 | 0.041 |
| % Growth | 21,450% | 95.8% | -111.7% | – |
| Operating Cash Flow | – | -$0 | $0 | -$0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | $0 | -$0 |